13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-18, with 27 holding rows worth $123,814,181.
- Accession
- 0001193125-26-227559
- Filer
- CIK 1822947
- Filed
- 2026-05-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 28 entries on the cover page, a total value of $123,814,181 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,814,181 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 32,810 | $10,571,054 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,655,500 | $9,974,388 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 200,000 | $6,696,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 200,000 | $6,696,000 | dollars as filed | put |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 2,818,459 | $6,256,979 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,045,000 | $5,778,850 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 80,859 | $5,672,259 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 766,974 | $5,522,213 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,000,000 | $5,290,000 | dollars as filed | call |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 414,219 | $5,260,581 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 161,000 | $5,071,500 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 300,000 | $4,905,000 | dollars as filed | call |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 660,375 | $4,781,115 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 900,000 | $4,230,000 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 745,300 | $4,136,415 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 926,557 | $3,863,743 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 33,712 | $3,753,831 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 166,959 | $3,678,107 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 202,124 | $3,634,190 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 113,899 | $3,462,530 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 100,000 | $2,985,000 | dollars as filed | call |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 817,939 | $2,821,890 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 1,325,000 | $2,226,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 246,900 | $1,888,785 | dollars as filed | call |
| AN2 THERAPEUTICS INC | 037326105 | COM | 526,315 | $1,799,997 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 210,525 | $1,465,254 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 250,000 | $1,392,500 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-227559 | this filing | 2026-05-18 | acceptance time not in the bulk data set |